News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,926 Results
Type
Article (2022)
Company Profile (13)
Press Release (17891)
Multimedia
Podcasts (5)
Webinars (1)
Section
Business (5950)
Career Advice (62)
Deals (794)
Drug Development (3239)
Employer Resources (3)
FDA (597)
Job Trends (761)
News (10276)
Policy (732)
Tag
Academia (279)
Adcomms (2)
Allergies (1)
Alliances (1740)
ALS (11)
Alzheimer's disease (296)
Antibody-drug conjugate (ADC) (5)
Approvals (595)
Artificial intelligence (17)
Autoimmune disease (1)
Automation (2)
Bankruptcy (5)
Best Places to Work (739)
Biosimilars (2)
Biotechnology (11)
Brain cancer (4)
Cancer (38)
Cardiovascular disease (3)
Career advice (49)
Career pathing (2)
CAR-T (4)
Cell therapy (11)
Cervical cancer (1)
Clinical research (2546)
Collaboration (54)
Compensation (12)
Complete response letters (1)
COVID-19 (45)
C-suite (20)
Data (110)
Depression (29)
Diabetes (3)
Diagnostics (71)
Diversity, equity & inclusion (1)
Drug discovery (4)
Duchenne muscular dystrophy (7)
Earnings (1403)
Editorial (5)
Employer branding (1)
Employer resources (3)
Events (2826)
Executive appointments (54)
FDA (645)
Funding (43)
Gene therapy (11)
GLP-1 (25)
Government (76)
Guidances (4)
Healthcare (573)
Huntington's disease (4)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (1)
Infectious disease (45)
Inflammatory bowel disease (10)
Inflation Reduction Act (1)
Intellectual property (3)
Interviews (12)
IPO (305)
IRA (1)
Job creations (93)
Job search strategy (45)
Layoffs (24)
Legal (93)
Liver cancer (1)
Lung cancer (4)
Lymphoma (3)
Management (1)
Manufacturing (7)
Medical device (295)
Medtech (296)
Mergers & acquisitions (521)
Metabolic disorders (9)
Multiple sclerosis (20)
Neurodegenerative disease (22)
Neuropsychiatric disorders (12)
Neuroscience (479)
NextGen: Class of 2025 (229)
Non-profit (219)
Now hiring (3)
Obesity (6)
Opinion (8)
Ovarian cancer (3)
Pain (9)
Pancreatic cancer (2)
Parkinson's disease (41)
Patents (11)
Patient recruitment (3)
People (2576)
Pharmaceutical (2)
Phase I (572)
Phase II (945)
Phase III (1164)
Pipeline (55)
Policy (4)
Postmarket research (133)
Preclinical (374)
Prostate cancer (1)
Psychedelics (7)
Radiopharmaceuticals (6)
Rare diseases (17)
Real estate (150)
Recruiting (1)
Regulatory (634)
Research institute (236)
Resumes & cover letters (9)
Rett syndrome (2)
Schizophrenia (38)
Series A (10)
Series B (4)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (31)
Sponsored (1)
Startups (144)
Supply chain (1)
Tariffs (2)
The Weekly (5)
Vaccines (8)
Venture capitalists (5)
Weight loss (3)
Date
Last 7 days (35)
Last 30 days (105)
Last 365 days (1516)
2025 (509)
2024 (1587)
2023 (1664)
2022 (1833)
2021 (2033)
2020 (1598)
2019 (1355)
2018 (1041)
2017 (1059)
2016 (1051)
2015 (1211)
2014 (863)
2013 (635)
2012 (610)
2011 (530)
2010 (456)
Location
Africa (17)
Arizona (5)
Arkansas (1)
Asia (1364)
Australia (173)
California (319)
Canada (107)
China (28)
Colorado (7)
Connecticut (28)
Delaware (1)
Europe (3251)
Florida (58)
Georgia (2)
Idaho (2)
Illinois (71)
Indiana (18)
Japan (8)
Kentucky (1)
Maine (4)
Maryland (35)
Massachusetts (249)
Michigan (1)
Minnesota (11)
Montana (1)
Nebraska (1)
Nevada (3)
New Hampshire (3)
New Jersey (60)
New Mexico (1)
New York (115)
North Carolina (13)
Northern California (103)
Ohio (8)
Pennsylvania (65)
Rhode Island (1)
South America (18)
South Carolina (1)
Southern California (176)
Tennessee (3)
Texas (14)
United States (1088)
Utah (8)
Virginia (2)
Washington D.C. (4)
Washington State (15)
Wisconsin (2)
19,926 Results for "soin neuroscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Soin Neuroscience Tests Very Low Frequency Spinal Cord Stimulation in Humans
Soin Neuroscience has announced that it has tested its TunedTX platform using very low frequency stimulation.
July 26, 2023
·
2 min read
Neurodegenerative disease
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, which today began a rolling BLA for accelerated approval.
April 2, 2025
·
5 min read
·
Dan Samorodnitsky
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro altogether.
April 29, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Alto Neuroscience to Participate in the JonesResearch Virtual CNS Day
April 22, 2025
·
1 min read
Press Releases
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
May 1, 2025
·
2 min read
Press Releases
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
May 1, 2025
·
3 min read
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
Press Releases
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
April 1, 2025
·
3 min read
Press Releases
Precision Neuroscience Receives FDA Clearance for High-Resolution Cortical Electrode Array
April 17, 2025
·
3 min read
Press Releases
ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights
April 1, 2025
·
14 min read
1 of 1,993
Next
